Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
2 Small-Cap Growth Stocks With Room To Run Motley Fool - Wed Apr 24, 7:30AM CDT

These two small-cap growth stocks could be ready to run.

REGN : 906.54 (-0.09%)
RHHBY : 30.5400 (-2.24%)
ACHR : 3.97 (-1.00%)
OCUL : 4.64 (-7.10%)
Ocular Therapeutix: Q4 Earnings Snapshot AP - Mon Mar 11, 3:26PM CDT

Ocular Therapeutix: Q4 Earnings Snapshot

OCUL : 4.64 (-7.10%)
Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024 Motley Fool - Wed Jan 3, 12:15PM CST

These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky.

BIIB : 201.99 (+4.56%)
XBI : 83.94 (-0.89%)
XLK : 198.03 (+0.46%)
OCUL : 4.64 (-7.10%)
LRMR : 6.46 (unch)
Ocular Therapeutix: Q3 Earnings Snapshot AP - Tue Nov 7, 2023

Ocular Therapeutix: Q3 Earnings Snapshot

OCUL : 4.64 (-7.10%)
AffaMed Therapeutics Announces First Patient Treated in Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery PR Newswire - Wed Sep 20, 2023

/PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical,...

OCUL : 4.64 (-7.10%)
Ocular Therapeutix: Q2 Earnings Snapshot AP - Mon Aug 7, 2023

Ocular Therapeutix: Q2 Earnings Snapshot

OCUL : 4.64 (-7.10%)
Wall Street - shutterstock_1321462400
Stocks Set to Open Higher as Investors Await Fed Meeting, Inflation Data Barchart - Mon Jun 12, 2023

June S&P 500 futures (ESM23) are up +0.23%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.46% this morning as market participants looked ahead to the latest U.S. inflation data and the Federal Reserve’s...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
TSLA : 162.13 (+12.06%)
GM : 45.08 (-0.04%)
ADBE : 477.12 (+0.89%)
NFLX : 555.12 (-3.92%)
TGT : 165.34 (-0.70%)
CMA : 52.95 (+0.59%)
ZION : 42.17 (+1.01%)
ADS.D.DX : 227.400 (+0.04%)
NOVN.Z.IX : 89.170 (+3.09%)
GF.Z.IX : 64.050 (-6.12%)
AffaMed Therapeutics Announces Completion of Patient Enrollment in the Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Cataract Surgery Patients PR Newswire - Wed May 31, 2023

/PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical,...

OCUL : 4.64 (-7.10%)
Ocular Therapeutix (OCUL) Reports Q1 Loss, Lags Revenue Estimates Zacks - Mon May 8, 2023

Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -14.81% and 4.62%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

OCUL : 4.64 (-7.10%)
XERS : 1.7600 (-1.12%)
Ocular Therapeutix: Q1 Earnings Snapshot AP - Mon May 8, 2023

Ocular Therapeutix: Q1 Earnings Snapshot

OCUL : 4.64 (-7.10%)

Barchart Exclusives

3 Dividend Aristocrats to Buy on Every Dip Barchart - Wed Apr 24, 6:30PM CDT
As markets get wobbly, here are three Dividend Aristocrats to add a little stability to any portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot